Update on immunopathogenesis and immunotherapy in multiple sclerosis
Rebecca C Selter,1 Bernhard Hemmer1–3 1Department of Neurology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany; 2Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; 3Competence Network on Multiple Sklerosis, Munich, Germany Abstrac...
Main Authors: | Selter RC, Hemmer B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-04-01
|
Series: | ImmunoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/update-on-immunopathogenesis-and-immunotherapy-in-multiple-sclerosis-peer-reviewed-article-ITT |
Similar Items
-
The role of natural killer cells in multiple sclerosisand their therapeutic implications
by: Coralie eChanvillard, et al.
Published: (2013-03-01) -
Steps in Multiple Sclerosis Pathogenesis - II: The Role of Biological Markers, Sodium Channels and Glutamate in Neurodegeneration
by: Ömer Faruk Aydın, et al.
Published: (2006-04-01) -
Interleukin-33 plasma levels in patients with relapsing-remitting multiple sclerosis
by: Alsahebfosoul Fereshteh, et al.
Published: (2017-03-01) -
Status of Immunotherapy Acceptance in Chinese Patients With Multiple Sclerosis: Analysis of Multiple Sclerosis Patient Survival Report 2018
by: Ran Zhou, et al.
Published: (2021-04-01) -
Pharmacoeconomic aspects of poor adherence to treatment in multiple sclerosis management
by: Mario Eandi
Published: (2011-09-01)